Stoke Therapeutics Inc buy Chardan Capital
Start price
20.12.24
/
50%
€10.70
Target price
20.12.25
€23.06
Performance (%)
152.34%
End price
21.12.25
€27.00
Summary
This prediction ended on 21.12.25 with a price of €27.00. With a performance of 152.34% the BUY prediction by Chardan_Capital was a big success. Chardan_Capital has a follow-up prediction for Stoke Therapeutics Inc where he still thinks Stoke Therapeutics Inc is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Stoke Therapeutics Inc | -3.472% | -3.472% | 379.310% |
| iShares Core DAX® | 2.489% | -5.941% | 2.896% |
| iShares Nasdaq 100 | 1.649% | -2.462% | 15.754% |
| iShares Nikkei 225® | 0.555% | -7.597% | 30.353% |
| iShares S&P 500 | 1.347% | -2.943% | 10.338% |
Comments by Chardan_Capital for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $24.00 price target on the stock.
Ratings data for STOK provided by MarketBeat
In the thread Trading Stoke Therapeutics Inc
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€13.80
13.08.25
13.08.25
€20.55
13.08.26
13.08.26
101.45%
30.03.26
30.03.26
Stopped prediction by Chardan_Capital for Stoke Therapeutics Inc
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
18.03.26
18.03.26
€30.34
18.03.27
18.03.27
4.51%
30.03.26
30.03.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€25.80
05.01.26
05.01.26
€29.93
05.01.27
05.01.27
7.75%
30.03.26
30.03.26
Stoke Therapeutics Inc
Start price
Target price
Perf. (%)
€8.95
19.02.25
19.02.25
€23.00
19.02.26
19.02.26
221.79%
20.02.26
20.02.26